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Abstract
Corneal transparency is attributed to the regular spacing and diameter
of collagen fibrils, and proteoglycans may play a role in fibrillogenesis
and matrix assembly. Corneal scar tissue is opaque and this opacity is
explained by decreased ultrastructural order that may be related to
proteoglycan composition. Thus, the objectives of the present study
were to characterize the proteoglycans synthesized by human corneal
explants and to investigate the effect of mechanical epithelial debride-
ment. Human corneas unsuitable for transplants were immersed in F-
12 culture medium and maintained under tissue culture conditions.
The proteoglycans synthesized in 24 h were labeled metabolically by
the addition of 35S-sulfate to the medium. These compounds were
extracted by 4 M GuHCl and identified by a combination of agarose
gel electrophoresis, enzymatic degradation with protease and muco-
polysaccharidases, and immunoblotting. Decorin was identified as the
main dermatan sulfate proteoglycan and keratan sulfate proteoglycans
were also prominent components. When the glycosaminoglycan side
chains were analyzed, only keratan sulfate and dermatan sulfate were
detected (~50% each). Nevertheless, when these compounds were 35S-
labeled metabolically, the label in dermatan sulfate was greater than in
keratan sulfate, suggesting a lower synthesis rate for keratan sulfate.
35S-Heparan sulfate also appeared. The removal of the epithelial layer
caused a decrease in heparan sulfate labeling and induced the synthe-
sis of dermatan sulfate by the stroma. The increased deposit of
dermatan sulfate proteoglycans in the stroma suggests a functional
relationship between epithelium and stroma that could be related to
the corneal opacity that may appear after epithelial cell debridement.
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The cornea consists of a thick central
portion, the stroma, that constitutes about
90% of the corneal thickness, lined anteri-
orly by an epithelial cell layer and posteri-
orly by an endothelium. The two cell layers
are separated from the stroma by basement
membranes. The cornea is characterized by
its transparency and curvature, which pro-
vide the initial focusing of the light image
into the eye. The stromal cells secrete an
extracellular matrix composed mainly of col-
lagen fibrils surrounded by proteoglycans,
arranged in orthogonal lamellae (1).
Proteoglycans are macromolecules com-
posed by a protein core with covalently linked
glycosaminoglycan side chains (2). In many
species, the predominant corneal glycosami-
noglycans are dermatan sulfate and keratan
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sulfate, with smaller amounts of heparan
sulfate. In 1992, a cDNA clone encoding the
core protein of a chick corneal keratan sul-
fate proteoglycan, named lumican, was ob-
tained (3), and the bovine (4) and human (5)
lumican core proteins were later cloned. Two
other keratan sulfate proteoglycans, named
keratocan and mimecan (or osteoglycin),
were cloned from the bovine cornea (6). It
seems that although expressed in other tis-
sues, only in the cornea are lumican, kerato-
can, and mimecan glycosylated with sul-
fated keratan sulfate chains. The main chick
corneal dermatan sulfate proteoglycan was
identified as decorin (7).
The transparency of the cornea is attrib-
uted to the regular spacing and diameter of
corneal fibrils, and proteoglycans are thought
to play a role in collagen fibrillogenesis and
matrix assembly. The keratan sulfate proteo-
glycans possibly function in the stroma by
fitting in between and interacting with the
collagen fibrils so as to maintain the fibrils at
a uniform diameter and spacing. The crucial
role of lumican in the regulation of collagen
assembly into fibrils has been established by
studies on mice homozygous for a null muta-
tion in lumican. These animals presented
skin laxity and fragility and bilateral corneal
opacity (8). Furthermore, studies on chick
embryo corneal development suggest that
the glycosylation is very important to the
corneal transparency process. Lumican with
non-sulfated keratan sulfate side chains was
detected on the 7th day of embryonic devel-
opment but sulfated glycosaminoglycan side
chains were detected only on the 15th day,
when transparency starts to increase (9).
These findings suggest that the sulfation of
keratan sulfate in lumican may be important
for the development of corneal transparency,
possibly leading to organization and optimal
hydration of the corneal tissue.
On the other hand, there is evidence sug-
gesting that dermatan sulfate proteoglycans
are not involved in the regulation of collagen
fibril diameter, but are important for fibril-
fibril spacing and lamellar cohesiveness (10).
In corneal explants from chicken embryos,
an increased synthesis of keratan sulfate pro-
teoglycan and a decreased synthesis of der-
matan sulfate proteoglycan coincide with
the onset of tissue transparency, again sug-
gesting a correlation between proteoglycan
composition and corneal transparency (11).
Corneal wound healing following trauma
or keratectomy is a major problem because
the regeneration of the stromal tissue causes
a subepithelial haze. Corneal scar tissue is
opaque and this opacity is explained by a
decreased ultrastructural order. As the regu-
lar spacing of collagen fibrils in normal adult
stroma is thought to be governed by proteo-
glycans, the corneal haze could be related to
changes in proteoglycan composition of the
corneal stroma. Although many biochemical
consequences of epithelial debridement by
chemical, mechanical and laser treatment
have been reported, controversial data were
obtained by different groups concerning the
corneal proteoglycan composition after epi-
thelial injury (12,13).
Although several groups have studied
the glycosaminoglycan composition of the
cornea, as well as the biosynthesis of proteo-
glycans by rabbit and chicken embryo cor-
neal explants, only a few reports concerning
human corneal glycosaminoglycans are avail-
able (14,15). We have recently shown that
the predominant human cornea glycosami-
noglycans are dermatan sulfate and keratan
sulfate (about 50% each), but these com-
pounds were not uniformly labeled when
cornea explants were incubated with 35S-
sulfate, suggesting lower metabolic rates for
keratan sulfate (15). Furthermore, 35S-hepa-
ran sulfate also appeared (12% of labeled
glycosaminoglycans) and was the main gly-
cosaminoglycan synthesized by epithelial
cells (15). Nevertheless, the proteoglycans
have not been characterized.
The present paper describes the proteo-
glycan composition of human corneal ex-
plants and the changes that occurred when
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the corneas were submitted to mechanical
epithelial debridement.
Human donor corneas that were unsuit-
able for transplantation were obtained from
Banco de Olhos do Hospital Sªo Paulo (Sªo
Paulo, SP, Brazil). The corneas were excised
from the eyes with 1.5 mm scleral rims under
sterile conditions, washed with 5 ml of a 4
mg/ml gentamicin solution in PBS and im-
mediately placed in 12 ml of Ham F-12
nutrient mixture supplemented with 10%
FBS, 10,000 U penicillin, and 100 mg strep-
tomycin. These explants were cultured for
various periods of time at 37oC in a humidi-
fied atmosphere of 2.5% CO2. When culture
time was more than  three days, the nutrient
medium was changed every three days.
For metabolic labeling, the corneas were
trimmed free of the scleral rims and serum-
free fresh Ham F-12 culture medium con-
taining 100 µCi/ml 35S-sulfate was added.
The corneas were labeled with 35S-sulfate
for 24 h. After 35S-incorporation, the cor-
neas were retrieved and washed twice with
PBS and the proteoglycans were extracted
and analyzed.
To investigate the effect of epithelial re-
moval, before excision from the eyes the
central 6.5 mm or the total area of the cor-
neas was submitted to mechanical epithelial
debridement. The other cornea from the same
donor was maintained intact as a control.
The corneas were excised and the corneal
explants were submitted to the tissue culture
conditions and metabolic labeling of macro-
molecules described above.
The corneal explants were then recov-
ered, weighed, cut into small pieces, and
suspended in 4 M guanidine hydrochloride
(GuHCl) in 0.5 M sodium acetate buffer, pH
5.8. After overnight incubation at 4oC with
shaking, debris were removed by centrifuga-
tion and the proteoglycans were precipitated
by the addition of ethanol (3 volumes) to the
supernatant. Subsequently, the precipitates
formed were collected by centrifugation,
washed with 80% ethanol and dried. The
dried material was resuspended in 100 µl
distilled water and analyzed for proteogly-
cans by a combination of agarose gel electro-
phoresis and enzymatic degradation with
specific mucopolysaccharidases (15,16). For
the analysis of glycosaminoglycans, the pro-
teoglycans were submitted to proteolysis with
papain (2 mg/ml in 0.06 M phosphate-cys-
teine buffer, pH 6.5, containing 20 mM
EDTA) as previously described (15). The
proteoglycans and their degradation prod-
ucts were fixed on the gel with cetyltri-
methylammonium bromide, and stained with
toluidine blue. The 35S-labeled compounds
were visualized by exposure of the agarose
gel slabs (after fixation, drying and staining)
to Kodak SB-5 X-ray film for 1 to 3 days. For
quantification, they were scraped off the
agarose gels and counted in an Ultima Gold
LSC-cocktail with a Beckman 6800 liquid
scintillation spectrophotometer. Alterna-
tively, a Packard Cyclone Storage Phos-
phor System was used to visualize and quan-
tify the 35S-labeled compounds.
Figure 1 shows the electrophoretic mi-
gration of 35S-proteoglycans and 35S-gly-
cosaminoglycans extracted from human cor-
neal explants, stained with toluidine blue
(total) and visualized by radioautography
(35S-labeled). The figure also shows the im-
munoblot of these compounds with an anti-
decorin polyclonal antibody and with MST1,
an anti-keratan sulfate monoclonal antibody
(17). The proteoglycans migrated as a poly-
disperse band (Figure 1B, PG). Upon incu-
bation of the proteoglycans with papain, the
band corresponding to proteoglycans com-
pletely disappeared and the band(s) corre-
sponding to free glycosaminoglycan chains
could be recognized (Figure 1A). Only one
band corresponding to the migration of der-
matan sulfate and keratan sulfate was stained
with toluidine blue (Figure 1B, GAG). In
contrast, a second band migrating as heparan
sulfate was identified in the radioautogram,
indicating a high specific activity for this
glycosaminoglycan, that was totally degraded
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by a mixture of heparitinases I and II from
Flavobacterium heparinum. The band mi-
grating as dermatan sulfate/keratan sulfate
was resistant to heparitinases I and II but was
partially degraded by keratanase and chon-
droitinase B, indicating that it contains a
mixture of keratan sulfate and dermatan sul-
fate. The dermatan sulfate proteoglycan was
identified as decorin by immunoblotting us-
ing a polyclonal anti-decorin antibody and
the keratan sulfate proteoglycan was identi-
fied with MST1, a monoclonal antibody that
recognizes keratan sulfate both as free chains
and as proteoglycans. The keratan sulfate
Figure 1 - Agarose gel electrophoresis of proteoglycans and glycosaminoglycans extracted from human corneas. Aliquots (5 µl) of papain-digested
proteoglycans (panel A), or intact proteoglycans (PG) and glycosaminoglycans (GAG) (panel B) extracted from human corneas were submitted to
agarose gel electrophoresis in 0.05 M 1,3-diaminopropane acetate buffer, pH 9.0, at 5 V/cm for 1 h. The proteoglycans and glycosaminoglycans were
fixed in the gel by 0.1% cetyltrimethylammonium bromide and stained with toluidine blue, as previously described (15). The 35S-labeled compounds
were observed by radioautography. Decorin (a dermatan sulfate proteoglycan) and keratan sulfate were also identified by immunoblotting stained with
an anti-decorin polyclonal antibody and MST1 (an anti-keratan sulfate monoclonal antibody). M: Mixture of standard glycosaminoglycans containing
chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate (KS), and heparan sulfate (HS).
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staining disappeared after treatment of the
glycosaminoglycans with keratanase, but not
with other mucopolysaccharidases.
35S-Incorporation was not uniformly dis-
tributed between dermatan sulfate and kera-
tan sulfate (Figure 2, control). Most of the
radioisotope was incorporated into derma-
tan sulfate, but also keratan sulfate and hep-
aran sulfate were labeled. About 15% of the
radioisotope label was found in keratan sul-
fate and 12% in heparan sulfate. The lower
specific activity of keratan sulfate suggests a
lower turnover rate for this glycosaminogly-
can when compared to dermatan sulfate and
heparan sulfate.
Most investigators who have studied the
biosynthesis of corneal polysaccharides in
adult organ culture by isotope incorporation
have reported that the biosynthesis pattern
changes with incubation time. A decrease in
the synthesis of keratan sulfate has been
reported for bovine (18) and rabbit (19) cor-
neas, but it should be noted that the rate of
synthesis does not necessarily reflect their
steady-state concentrations (compare total
and 35S-glycosaminoglycans, Figure 2).
The epithelium of the cornea has a bar-
rier function, impairing the diffusion of wa-
ter and solutes to the stroma, as well as the
penetration of microorganisms and foreign
bodies. It also interacts with the tear film
providing a smooth surface to the cornea,
which is very important for light transmis-
sion. An active interaction between the epi-
thelium and the stroma has been demon-
strated in both normal and pathological pro-
cesses, such as development, wound healing
and tissue remodeling. The removal of the
epithelium would modify the chemical and
physical equilibrium between the epithelium
and the stroma and the stromal environment
would change as a consequence of the epi-
thelial barrier damage. In the wound healing
process, TGF-ß, EGF, and interleukins are
secreted by the epithelium and act on the
stroma regulating cell proliferation, differ-
entiation, migration, apoptosis, and extra-
cellular matrix production (fibronectin and
collagen) or degradation (induction of me-
talloproteinases). Nevertheless, the effects
Figure 2 - Total glycosaminoglycans (A) and 35S-labeled glycosaminoglycans (B) extracted
from explants of intact or epithelium-debrided human corneas. Total glycosaminoglycans
were stained with toluidine blue and quantified by densitometry. The 35S-glycosaminogly-
cans were visualized by radioautography and scraped off the gels, and radioactivity was
measured with a liquid scintillation spectrophotometer. Data are reported as means ± SD of
14 experiments. GAG, Total glycosaminoglycan; DS, dermatan sulfate; KS, keratan sulfate;
HS, heparan sulfate.
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of epithelial debridement on proteoglycan
synthesis are poorly understood. The events
following epithelial damage might cause
modifications in proteoglycan synthesis by
the keratocytes.
 To examine the effect of epithelial de-
bridement on proteoglycan synthesis, the
epithelial cell layer was either partially re-
moved from a central disk 6.5 mm in diam-
eter or totally removed (limbus-to-limbus).
35S-Incorporation into glycosaminoglycan
side chains is also shown in Figure 2. The
concentration of glycosaminoglycans (ex-
pressed as mg/g of tissue wet weight) did not
change after epithelial removal (Figure 2,
total glycosaminoglycans), but a drastic in-
crease in isotope incorporation into derma-
tan sulfate was observed (Figure 2, 35S-gly-
cosaminoglycans). Conversely, 35S-incorpo-
ration into heparan sulfate decreased. Both
changes were more evident for total epitheli-
al debridement.
It is conceivable that the epithelial layer
can regulate the availability of radioactive
precursors for the stromal cells. Thus, the
increased radioisotope incorporation into gly-
cosaminoglycans in corneal explants sub-
mitted to epithelial debridement may be re-
lated to increased tissue permeability to 35S-
sulfate. Nevertheless, the labeling of keratan
sulfate was not increased, suggesting that the
higher incorporation of radioisotope in der-
matan sulfate is not a mere consequence of
higher isotope availability but a more specif-
ic phenomenon, possibly indicating a re-
sponse of stromal keratocytes to epithelial
removal and/or wounding. The decrease in
heparan sulfate labeling is in agreement with
our previous finding that heparan sulfate is
the main glycosaminoglycan synthesized by
epithelial cells (at least under culture condi-
tions) (15).
Our in vitro observations on the effects
of trauma to the cornea are of interest in view
of the effects of injury to the cornea ob-
served in vivo. Lower amounts of keratan
sulfate and replacement of keratan sulfate by
other glycosaminoglycans have been reported
in early wound healing, in corneal scars and
in other pathological conditions (20). Lumi-
can, keratocan and mimecan are transcribed
and translated several times more in the cor-
nea than in other tissues. Furthermore, a
tissue-specific glycosylation of these pro-
teins converts them to proteoglycans. Eluci-
dation of the mechanisms by which
keratocytes up-regulate expression of these
genes and then provide unique glycosylation
for selected sites on the proteins will greatly
enhance our understanding of how this tis-
sue obtains transparency and how transpar-
ency might be restored in pathological con-
ditions.
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